5 laboratory informatics enablers to help working remotely
With COVID-19 forcing many companies into undergoing a rapid and often premature digital transformation this can raise challenges for the business units.
In the laboratory it is almost impossible to perform all work remotely and we have seen multiple strategies such as rotating shifts to avoid infection and those who can work from home do so.
One of the main enabling factors is having the right laboratory informatics, LIMS, ELN and supporting infrastructure.
Away From the Bench During COVID-19: A Conversation with Dr. Colles Price
Colles Price, M.S., PhD is a Research Fellow in Medicine at Dana Farber Cancer Institute, Harvard Medical School, and a Postdoctoral Scholar, Cancer Program, Broad Institute. He is currently identifying and validating targets from the Cancer Dependency Map. In particular, he is interested in understanding the anti-cancer effects of hypoxia-related genes and how polar-related genes control cell proliferation and viability. We had the chance to sit down with him and learn about how COVID-19 is affecting his research.
How Biotech Labs are Adjusting to the COVID-19 Era
As an industry that relies on having employees in the lab, biotech has been disrupted by COVID-19 and the dramatic and unexpected set of changes it has introduced. For many scientists, working remotely is a brand new concept. And yet, the scientific industry is also being called upon to develop tests, therapies, and vaccines that put this crisis to rest.
To share how biotechs around the world are managing their projects, caring for their people, and supporting the community during coronavirus, we built a guide with best practices and unique ideas from our customers.
Proscia® Offers Concentriq® Digital Pathology Software for Remote Use in Clinical Practice in the United States
Proscia® has made available the Concentriq Dx® digital pathology software for use in reviewing and reporting of digital pathology slides in the United States. Concentriq Dx, which is CE-marked for use in primary diagnosis in Europe, will support the need for remote pathology in the United States brought about by the COVID-19 pandemic.Laboratory Informatics Weekly Update – Volume 18, Issue 17
April 28, 2020 Laboratory Informatics Weekly Update Volume 18, Issue 17 In This Issue Featured Books CannaQA Catalog & Price List Featured Content 04/28/2020 - 5 laboratory informatics enablers to help working remotelyWith COVID-19 forcing many companies into undergoing a rapid and often premature digital transformation this can raise challenges for the business units. In the laboratory it is almost impossible to perform all work remotely and we have seen multiple strategies such as rotating shifts to avoid infection and those who can work from home do so. One of the main enabling factors is having the right laboratory…Epidemiological data challenges: Planning for a more robust future through data standards
This week we turn back the clock a couple of years to 2018, when Fairchild et al.published in the journal Frontiers in Public Health their analysis of the challenges of epidemiological data reporting. With the march of COVID-19 today, their analysis and advice holds even more relevant today. In their paper, Fairchild et al. first introduced the state of epidemiological data reporting, particularly on the internet. They then discussed the three challenges that affect such reporting: user interface, data format, and data reporting issues. They concluded with nine clear best practices that should be followed when managing epidemiological data for release to the public. They imagined a scenario of a standardized platform adopted worldwide, "where global data could be easily collected without the challenges we currently face. This would in turn streamline epidemiological and public health analysis, modeling, and informatics, resulting in better public health decision-making capabilities."
Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing
Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be used to verify the presence of the SARS-CoV-2 virus. They are intended to be used for both research and development and IVD diagnostic applications.Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
Illumina, Inc. announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to critical public databases. Illumina is making the toolkit available at no cost to the global research community in support of efforts to combat the pandemic.The Race to Develop Treatments and Vaccines for COVID-19
The coronavirus pandemic has now reached nearly every country in the world, with cases being confirmed in more than 200 countries and territories. As of April 10th, 2020, there have been over 1.6 million cases reported globally. The actual numbers of cases are believed to be much higher due to testing shortages, unreported cases, and suspicions that some countries have not been accurately reporting the scope of their outbreaks.
With COVID-19 continuing to spread across the globe, many pharmaceutical and biotechnology companies are racing to develop vaccines and effective therapeutics to address the pandemic. As the premier laboratory informatics service provider for the life science industry, Astrix Technology Group is proud to support many of the companies on the front lines in this effort. In this blog, we will highlight some of the groundbreaking work being done right now by our customers to combat COVID-19.
Autoscribe Informatics Announces LIMS Distributor in West Africa
Autoscribe Informatics is delighted to announce that it has appointed Promatics Technologies Nigeria as our distributor in Nigeria to sell, configure and support the Matrix family of Laboratory Information Management System (LIMS) products. Based in Abuja, Nigeria, Promatics Technologies provide a range of technology services and consulting solutions, including healthcare and clinical systems, to clients across the region.
Laboratory Informatics Weekly Update – Volume 18, Issue 16
April 21, 2020 Laboratory Informatics Weekly Update Volume 18, Issue 16 In This Issue Featured Books The Complete Guide to LIMS and Laboratory Informatics Featured Content 04/21/2020 - The Race to Develop Treatments and Vaccines for COVID-19The coronavirus pandemic has now reached nearly every country in the world, with cases being confirmed in more than 200 countries and territories. As of April 10th, 2020, there have been over 1.6 million cases reported globally. The actual numbers of cases are believed to be much higher due to testing shortages, unreported cases, and suspicions that some countries have not been accurately reporting the scope…Blockchain and artificial intelligence technology for novel coronavirus disease 2019 self-testing
In this brief editorial in the journal Diagnostics, Mashamba-Thompson et al. state their case for a potentially ideal solution to COVID-19 testing in resource-poor communities: using mobile health (mHealth) solutions in conjunction with a blockchain and AI-driven data acquisition and transfer system. They add that the "AI component of this technology enables powerful data collection (patient information, geographic location of the patient, and test results), security, analysis, and curation of disparate and clinical data sets from federated blockchain platforms to derive triangulated data at very high degrees of confidence and speed. " Unfortunately, what isn't clear in their argument is how the self-testing step would actually work, let alone how the system would realistically be implemented in resource-poor settings. One could argue, however, despite the relatively few details, the sharing of ideas on how to address COVID-19 testing in various environments still has value.
Sr. Platform Specialist – Quality & Lab Automation
Senior Platform Specialist – Quality and Lab Automation -Raleigh, NC area
Company Description
Company has one of the most exciting pipelines in the Biotech / Pharmaceutical industry. The company has been growing rapidly and with this growth comes a number of exciting opportunities to work with our expanding business areas.…
Recruiter
Senior Platform Specialist – Quality and Lab Automation -Raleigh, NC area
Company Description
Company has one of the most exciting pipelines in the Biotech / Pharmaceutical industry. The company has been growing rapidly and with this growth comes a number of exciting opportunities to work with our expanding business areas.…
Taking on the Pandemic: Transforming a Clinical Lab Into a COVID-19 Ready Lab
L7 Informatics Inc., and Contamination Source Identification (CSI) deploy 'ready to go' COVID-19 workflows based on the CDC testing protocol for testing laboratories supporting coronavirus patient screening.Studying #COVID19 around the world using the Hidex Sense microplate reader
Hidex Sense microplate reader used to research mechanisms, diagnostics, and therapeutic targets of SARS-CoV-2. As the global COVID-19 (also known as SARS-CoV-2) crisis continues to unfold, it’s important to recognise the scientists behind the vital studies investigating the virus. The current pressing task of epidemiologists and virologists around the world is studying the mechanisms and transmission of SARS-CoV-2, to better understand the virus whilst revealing therapeutic targets.How biotechs are racing to develop COVID-19 treatments – Part 2 of 3
The novel coronavirus has had sweeping effects on the world at large since its emergence last winter, and it will no doubt continue to affect and change the world we live in. As we do our part to shelter-in-place and practice social distancing, there are leagues of scientists and researchers working around the clock on therapeutics to treat patients infected with SARS-CoV 2.
This article is the second in a three-part series covering the response of biotech companies to the COVID-19 crisis. The first article in this series is: How biotechs are racing to develop COVID-19 tests.
Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat
Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team has launched a major research and diagnostics project to better understand and predict variation in COVID-19 severity and determine the complex genetic, environmental and lifestyle interactions that influence its pathogenicity in individuals. Later they will engage with clinical trials of novel antiviral agents and when available vaccines in order to predict responder/non-responder outcomes.Visiopharm and Proscia® Partner to Deliver AI-Enabled Solutions that Advance Precision Medicine
Visiopharm, the leader in precision pathology software, and Proscia, a leader in digital pathology image and workflow management, have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine.COVID-19 Testing and the Important Role of a LIMS
We are living in unprecedented times right now with the recent outbreak of SAR-CoV-2 and the global emergence of the COVID-19 pandemic. And now, as never before, our nation’s attention is focused on laboratories and the diagnostic industry at large. The quality of diagnostic testing during this time of international crisis will be talked about for years to come. Fortunately, many companies have joined the fight to help facilitate COVID-19 testing, as laboratories quickly ramp up to add this to their testing menu. Yet, while many of the news headlines focus on instrument manufacturers and new testing techniques, one element that is often overlooked is the critical role of a laboratory’s LIMS.
